ArticlePediatric nephrology (Berlin, Germany)2026
Impact of childhood and parental smoking and substance use on nephrotic syndrome outcomes: a prospective cohort study.
Article in Pediatric nephrology (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe impact of environmental exposures such as household and adolescent smoking, alcohol use, and drug use on childhood nephrotic syndrome outcomes is unknown. Our objective was to characterize tobacco, alcohol, and recreational drug use and longitudinal associations.
methodsAnalyzing data from Insight into Nephrotic Syndrome: Investigating Genes, Health, and Therapeutics, a prospective cohort, we included children (1-18 years) diagnosed with nephrotic syndrome from 1996 to 2023. Tobacco, alcohol, and recreational drug use were self-reported at annual study visits, treated as time-varying exposures. We evaluated prevalence and quantity of exposure to each substance and associations with relapse rate, steroid-sparing medication initiation, and hospitalizations using generalized linear mixed models.
resultsWe included 732 children with nephrotic syndrome (total of 2065 study visits). Median age at diagnosis was 3.8-years (IQR 2.7-6.3), 461 (73%) were male, and 692 (96%) were steroid-sensitive at diagnosis. Exposure to a household tobacco smoker was reported in 114 (16%) participants. Eight adolescents (1%) reported personal tobacco smoking, 33 (5%) used alcohol, and 10 (1%) used recreational drugs at any time. Personal or household tobacco smoking was not associated with relapse rate (adjusted rate ratio 1.22, 95% CI 0.96-1.54), steroid-sparing medication initiation (adjusted odds ratio 0.97, 95% CI 0.66-1.42), or hospitalization (adjusted odds ratio 0.66, 95% CI 0.31-1.37). Youth alcohol use was also not associated with nephrotic syndrome outcomes.
conclusionsUp to 5% of youth with nephrotic syndrome use tobacco, alcohol, or recreational drugs, and 16% are exposed to a household smoker. While this study was underpowered to evaluate the independent impact of personal tobacco and recreational drug use, no clear association between substance exposure and longitudinal outcomes was identified.
Indexed as
Identifiers
42498857What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.